FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
press_releaseUnited States·U.S. Food and Drug Administration·Wire Summary
Today, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advanced liver scarring) or with compensated cirrhosis.
AI Business Impact
How does this affect your business?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.